Fuso Pharmaceutical Industries,Ltd. (TYO:4538)

TYO:4538 Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2013	FY 2012	FY 2011
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011
Cash & Equivalents	4,638	6,264	5,120	9,120	4,278	3,833
Cash & Short-Term Investments	4,638	6,264	5,120	9,120	4,278	3,833
Cash Growth	-49.15%	22.34%	-43.86%	113.18%	11.61%	22.19%
Receivables	22,836	26,491	24,328	22,613	19,442	19,040
Inventory	14,846	14,941	14,202	8,247	7,345	6,463
Prepaid Expenses	-	275	275	-	-	-
Other Current Assets	9,844	371	1,022	166	299	197
Total Current Assets	52,164	48,342	44,947	40,893	32,114	30,103
Property, Plant & Equipment	22,620	23,110	24,424	22,490	23,717	24,067
Long-Term Investments	9,198	4,375	3,924	8,067	5,499	5,033
Other Intangible Assets	1,449	1,513	600	376	166	201
Long-Term Deferred Tax Assets	-	296	396	-	-	-
Other Long-Term Assets	2	1,417	1,511	3	2	1
Total Assets	85,433	79,053	75,802	71,849	61,528	59,453
Accounts Payable	4,155	3,998	7,352	12,178	11,347	11,249
Accrued Expenses	9,704	1,765	1,318	996	809	825
Short-Term Debt	27,633	22,630	12,413	6,920	6,713	6,168
Current Portion of Long-Term Debt	-	827	3,351	100	100	100
Current Portion of Leases	-	-	-	2	1	1
Current Income Taxes Payable	389	949	270	3,606	1,595	1,516
Other Current Liabilities	5,547	5,218	4,946	3,733	3,707	3,434
Total Current Liabilities	47,428	35,387	29,650	27,535	24,272	23,293
Long-Term Debt	2,144	2,462	7,021	6,191	6,679	5,734
Long-Term Leases	-	-	-	4	-	2
Pension & Post-Retirement Benefits	103	506	889	1,577	1,488	1,259
Long-Term Deferred Tax Liabilities	-	1,315	1,315	2,750	2,208	2,606
Other Long-Term Liabilities	1,750	272	266	695	282	296
Total Liabilities	51,425	39,942	39,141	38,752	34,929	33,190
Common Stock	10,758	10,758	10,758	10,758	10,758	10,758
Additional Paid-In Capital	14,951	14,951	14,951	15,010	15,010	15,010
Retained Earnings	13,085	18,680	16,541	10,841	6,201	6,372
Treasury Stock	-2,594	-2,593	-2,588	-1,414	-1,409	-1,406
Comprehensive Income & Other	-2,192	-2,685	-3,001	-2,098	-3,961	-4,471
Shareholders' Equity	34,008	39,111	36,661	33,097	26,599	26,263
Total Liabilities & Equity	85,433	79,053	75,802	71,849	61,528	59,453
Total Debt	29,777	25,919	22,785	13,217	13,493	12,005
Net Cash (Debt)	-25,139	-19,655	-17,665	-4,097	-9,215	-8,172
Net Cash Per Share	-2943.51	-2300.83	-2051.55	-452.52	-1017.64	-902.23
Filing Date Shares Outstanding	8.54	8.54	8.61	9.05	9.05	9.06
Total Common Shares Outstanding	8.54	8.54	8.61	9.05	9.05	9.06
Working Capital	4,736	12,955	15,297	13,358	7,842	6,810
Book Value Per Share	3982.82	4579.55	4257.67	3656.06	2937.67	2900.11
Tangible Book Value	32,559	37,598	36,061	32,721	26,433	26,062
Tangible Book Value Per Share	3813.12	4402.39	4187.99	3614.52	2919.33	2877.91
Land	-	8,818	8,818	-	-	-
Buildings	-	34,746	34,599	-	-	-
Machinery	-	34,521	33,985	-	-	-
Construction In Progress	-	174	246	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.